Emergence of Biosimilar Medicines – The Biosimilar Company Point of View, Paul Greenland, Belgium Federal Parliament, Brussels, 22 November 2012 (PPT)

EMA Questions and Answers on Biosimilar Medicines (Similar Biological Medicinal Products)